ALPS Medical Breakthroughs ETF
SBIO
#2250
ETF rank
โ‚ฌ0.18 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
56,95ย โ‚ฌ
Share price
2.17%
Change (1 day)
104.13%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of July 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of July 2026: 0.5%